» Articles » PMID: 15087308

Atherosclerosis in the Apolipoprotein-E-deficient Mouse: a Decade of Progress

Overview
Date 2004 Apr 17
PMID 15087308
Citations 183
Authors
Affiliations
Soon will be listed here.
Abstract

Arguably the most critical advancement in the elucidation of factors affecting atherogenesis has been the development of mouse models of atherosclerosis. Among available models, the apolipoprotein E-deficient (apoE-/-) mouse is particularly popular because of its propensity to spontaneously develop atherosclerotic lesions on a standard chow diet. A Medline search reveals over 645 articles dedicated to studies using this reliable and convenient "super" animal model since its inception (Piedrahita JA et al, Proc Natl Acad Sci U S A 1992;89:4471-4475; Plump AS et al, Cell 1992;71:343-353) with a more or less steady increase from year to year. This review will examine our present understanding of the pathology and progression of plaques in this animal and highlight some of the nutritional, pharmacological, and genetic studies that have enhanced this understanding.

Citing Articles

Alternate day fasting aggravates atherosclerosis through the suppression of hepatic ATF3 in mice.

Deng Y, Yang X, Ye X, Yuan Y, Zhang Y, Teng F Life Metab. 2025; 3(3):loae009.

PMID: 39872376 PMC: 11749235. DOI: 10.1093/lifemeta/loae009.


Circulating metabolites of Borneolum syntheticum (Bingpian) ameliorate atherosclerosis in ApoE mice via inhibiting macrophage foam-cell formation.

He R, Ma C, He X, Dong Y, Li H, Chu Z Acta Pharmacol Sin. 2024; 46(3):759-776.

PMID: 39472494 PMC: 11845446. DOI: 10.1038/s41401-024-01406-5.


Dietary ellagic acid blocks inflammation-associated atherosclerotic plaque formation in cholesterol-fed apoE-deficient mice.

Park S, Kang M, Kim D, Lim S, Kang Y Nutr Res Pract. 2024; 18(5):617-632.

PMID: 39398881 PMC: 11464280. DOI: 10.4162/nrp.2024.18.5.617.


Semi-quantitative elemental imaging of corrosion products from bioabsorbable Mg vascular implants .

He W, MacRenaris K, Griebel A, Kwesiga M, Freitas E, Gillette A Bioact Mater. 2024; 43():225-239.

PMID: 39386222 PMC: 11462046. DOI: 10.1016/j.bioactmat.2024.07.023.


Gastrin-releasing peptide receptor antagonist RC-3095 inhibits Porphyromonas gingivalis lipopolysaccharide-accelerated atherosclerosis by suppressing inflammatory responses in endothelial cells and macrophages.

Park H, Kim M, Kim Y, Kim H, Park H, Bae S Inflamm Res. 2024; 73(11):1833-1846.

PMID: 39164592 DOI: 10.1007/s00011-024-01934-0.